Abstract
Over the last few decades reconstructive surgery and general medicine has shifted from a resection-oriented approach towards strategies focusing on the repair and regeneration of tissues. Artificial tissue substitutes containing metals, ceramics and polymers, to maintain skeletal function [6], and artificial devices, such as pacemakers and insulin pumps, have been used to reach this goal. These artificial materials and devices have significantly improved the possibility for clinicians to restore the form and, to some extent, the function of defective bones as well as to increased life expectancy of patients, e.g. with valvular heart disease or diabetes mellitus. Despite the fact that every artificial device has specific disadvantages, the use of biomaterials is currently a common treatment option in clinical practice. More detailed understanding exists concerning the transplantation of cells and tissues; thus, autografts are the second mainstay in clinical practice. The advantages of transplanting the body’s own tissues ensure that autograft tissue transplantation can now be considered to be the “gold standard” in bone reconstruction. The reason for the primacy of tissue grafts over non-living biomaterials is that they contain living cells, thus possessing biological activity. The main disadvantages of using autografts are donor site morbidity and donor shortage [19]. Research is currently in progress into the use of cell-based approaches in reconstructive surgery, since cells are the driving elements for all repair and regeneration processes. As they synthesize and assemble the extracellular matrix, cells can be considered the basic unit needed for a biological regeneration strategy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amit M, Carpenter MK, Inokuma MS et al (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227:271-278
Arnold AS, Laporte V, Dumont S et al (2006) Comparing reagents for efficient transfection of human primary myoblasts: FuGENE 6, Effectene and ExGen 500. Fundam Clin Pharmacol 20:81-89
Atala A (2007) Engineering tissues, organs and cells. J Tissue Eng Regen Med 1:83-96
Avilion AA, Nicolis SK, Pevny LH et al (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17:126-140
Bielby RC, Boccaccini AR, Polak JM et al (2004) In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 10:1518-1525
Binderman I, Fin N (1990) Bone substitutesorganic, inorganic, and polymeric: Cell material interactions. In: Yamamuro T, Hench L and Wilson J eds) CRC Handbook of Bioactive Ceramics. CRC Press, Boca Raton, pp 45-51
Boiani M, Scholer HR (2005) Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 6:872-884
Brimble SN, Zeng X, Weiler DA et al (2004) Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13:585-597
Brimble SN, Sherrer ES, Uhl EW et al (2007) The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 25:54-62
Burt RK, Verda L, Kim DA et al (2004) Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease. J Exp Med 199:895-904
Chambers I, Colby D, Robertson M et al (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643-655
Chambers I (2004) The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells 6:386-391
Chaudhry GR, Yao D, Smith A et al (2004) Osteogenic cells derived from embryonic stem cells produced bone nodules in three-dimensional scaffolds. J Biomed Biotechnol 2004:203-210
Cibelli JB, Campbell KH, Seidel GE et al (2002) The health profile of cloned animals. Nat Biotechnol 20:13-14
Cogle CR, Guthrie SM, Sanders RC et al (2003) An overview of stem cell research and regulatory issues. Mayo Clin Proc 78:993-1003
Collas P (2007) Dedifferentiation of cells: new approaches. Cytotherapy 9:236-244
D’Ippolito G, Schiller PC, Ricordi C et al (1999) Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14:1115-1122
Daheron L, Opitz SL, Zaehres H et al (2004) LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells 22:770-778
Damien CJ, Parsons JR (1991) Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 2:187-208
Drab M, Haller H, Bychkov R et al (1997) From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. Faseb J 11:905-915
Dvash T, Mayshar Y, Darr H et al (2004) Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum Reprod 19:2875-2883
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156
Gilbert DM (2004) The future of human embryonic stem cell research: addressing ethical conflict with responsible scientific research. Med Sci Monit 10:RA99-103
Gurdon JB (1962) Adult frogs derived from the nuclei of single somatic cells. Dev Biol 4:256-273
Halleux C, Sottile V, Gasser JA et al (2001) Multi-lineage potential of human mesenchymal stem cells following clonal expansion. J Musculoskelet Neuronal Interact 2:71-76
Handschel J, Wiesmann HP, Depprich R et al (2006) Cell-based bone reconstruction therapies--cell sources. Int J Oral Maxillofac Implants 21:890-898
Handschel J, Berr K, Depprich R et al (2008) Osteogenic differentiation of embryonic stem cells. Head Face Med 4:10
Heng BC, Cao T, Stanton LW et al (2004) Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res 19:1379-1394
Hochedlinger K, Jaenisch R (2003) Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med 349:275-286
Itskovitz-Eldor J, Schuldiner M, Karsenti D et al (2000) Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6:88-95
Kitsberg D (2007) Human embryonic stem cells for tissue engineering. Methods Mol Med 140:33-65
Klimanskaya I, Chung Y, Meisner L et al (2005) Human embryonic stem cells derived without feeder cells. Lancet 365:1636-1641
Klug MG, Soonpaa MH, Koh GY et al (1996) Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98:216-224
Kogler G, Sensken S, Airey JA et al (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920-926
Lavon N, Yanuka O, Benvenisty N (2004) Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 72:230-238
Lee SH, Lumelsky N, Studer L et al (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18:675-679
Lysaght MJ, Reyes J (2001) The growth of tissue engineering. Tissue Eng 7:485-493
Maitra A, Arking DE, Shivapurkar N et al (2005) Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099-1103
Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634-7638
Matin MM, Walsh JR, Gokhale PJ et al (2004) Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22:659-668
McDonald JW, Liu XZ, Qu Y et al (1999) Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5:1410-1412
Menendez P, Wang L, Bhatia M (2005) Genetic manipulation of human embryonic stem cells: a system to study early human development and potential therapeutic applications. Curr Gene Ther 5:375-385
Mitsui K, Tokuzawa Y, Itoh H et al (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631-642
Moosmann S, Hutter J, Moser C et al (2005) Milieu-adopted in vitro and in vivo differentiation of mesenchymal tissues derived from different adult human CD34-negative progenitor cell clones. Cells Tissues Organs 179:91-101
Nash R, Neves L, Faast R et al (2007) The lectin Dolichos biflorus agglutinin recognizes glycan epitopes on the surface of murine embryonic stem cells: a new tool for characterizing pluripotent cells and early differentiation. Stem Cells 25:974-982
Nguyen TH, Murakami A, Fujiki K et al (2002) Transferrin-polyethylenimine conjugate, FuGENE6 and TransIT-LT as nonviral vectors for gene transfer to the corneal endothelium. Jpn J Ophthalmol 46:140-146
Nichols J, Zevnik B, Anastassiadis K et al (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391
Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376
Niwa H (2007) How is pluripotency determined and maintained? Development 134:635-646
Ohtsuka S, Dalton S (2008) Molecular and biological properties of pluripotent embryonic stem cells. Gene Ther 15:74-81
Oliveri RS (2007) Epigenetic dedifferentiation of somatic cells into pluripotency: cellular alchemy in the age of regenerative medicine? Regen Med 2:795-816
Pankratz MT, Li XJ, Lavaute TM et al (2007) Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25:1511-1520
Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
Quarto R, Thomas D, Liang CT (1995) Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 56:123-129
Reubinoff BE, Pera MF, Fong CY et al (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18:399-404
Salero E, Hatten ME (2007) Differentiation of ES cells into cerebellar neurons. Proc Natl Acad Sci U S A 104:2997-3002
Schuldiner M, Yanuka O, Itskovitz-Eldor J et al (2000) Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 97:11307-11312
Schulz LC, Ezashi T, Das P et al (2007) Human embryonic stem cells as models for trophoblast differentiation. Placenta 29(Suppl A):S10-S16
Siemen H, Nix M, Endl E et al (2005) Nucleofection of human embryonic stem cells. Stem Cells Dev 14:378-383
Smith AG, Heath JK, Donaldson DD et al (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336:688-690
Solter D (2000) Mammalian cloning: advances and limitations. Nat Rev Genet 1:199-207
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147
Trounson A (2002) Human embryonic stem cells: mother of all cell and tissue types. Reprod Biomed Online 4(Suppl 1):58-63
Urbach A, Schuldiner M, Benvenisty N (2004) Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 22:635-641
Wang G, Zhang H, Zhao Y et al (2005) Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun 330:934-942
Wilmut I, Young L, Campbell KH (1998) Embryonic and somatic cell cloning. Reprod Fertil Dev 10:639-643
Yamaguchi M, Hirayama F, Murahashi H et al (2002) Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum. Cytotherapy 4:109-118
Young LE, Sinclair KD, Wilmut I (1998) Large offspring syndrome in cattle and sheep. Rev Reprod 3:155-163
Zavazava N (2003) Embryonic stem cells and potency to induce transplantation tolerance. Expert Opin Biol Ther 3:5-13
zur Nieden NI, Kempka G, Rancourt DE et al (2005) Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev Biol 5:1
Zwaka TP, Thomson JA (2003) Homologous recombination in human embryonic stem cells. Nat Biotechnol 21:319-321
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Handschel, J., Meyer, U., Wiesmann, H. (2009). Embryonic Stem Cell Use. In: Meyer, U., Handschel, J., Wiesmann, H., Meyer, T. (eds) Fundamentals of Tissue Engineering and Regenerative Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77755-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-540-77755-7_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77754-0
Online ISBN: 978-3-540-77755-7
eBook Packages: MedicineMedicine (R0)